These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8437042)

  • 1. Home infusion of intravenous immune globulin in human immunodeficiency virus-infected children.
    Poole JK
    J Intraven Nurs; 1993; 16(1):18-22. PubMed ID: 8437042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immune globulin for the prevention of infections in children with symptomatic human immunodeficiency virus infection.
    Mofenson LM; Moye J
    Pediatr Res; 1993 Jan; 33(1 Suppl):S80-7; discussion S87-9. PubMed ID: 8433880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does intravenous immune globulin have a role in HIV-infected patients?
    Yap PL
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):59-67. PubMed ID: 8033437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).
    Stiehm ER; Fletcher CV; Mofenson LM; Palumbo PE; Kang M; Fenton T; Sapan CV; Meyer WA; Shearer WT; Hawkins E; Fowler MG; Bouquin P; Purdue L; Sloand EM; Nemo GJ; Wara D; Bryson YJ; Starr SE; Petru A; Burchett S
    J Infect Dis; 2000 Feb; 181(2):548-54. PubMed ID: 10669338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of intravenous immune globulin for the prevention of serious infections in adults with advanced human immunodeficiency virus infection.
    Kiehl MG; Stoll R; Broder M; Mueller C; Foerster EC; Domschke W
    Arch Intern Med; 1996 Dec 9-23; 156(22):2545-50. PubMed ID: 8951297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immune globulin for prevention of bacterial infections in pediatric AIDS patients.
    Crow ME
    Am J Health Syst Pharm; 1995 Apr; 52(8):803-11. PubMed ID: 7634115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with the use of immune intravenous immunoglobulin in symptomatic children with human immunodeficiency virus infection].
    Jiménez E; Carrer MT; Pérez Dieppa I; Ortiz L; Fernández M
    Bol Asoc Med P R; 1991 Dec; 83(12):538-42. PubMed ID: 1811606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of opportunistic DNA viral infections by multiplex PCR among HIV infected individuals receiving care at a tertiary care hospital in South India.
    Sachithanandham J; Ramamurthy M; Kannangai R; Daniel HD; Abraham OC; Rupali P; Pulimood SA; Abraham AM; Sridharan G
    Indian J Med Microbiol; 2009; 27(3):210-6. PubMed ID: 19584500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-lymphocytopaenia, opportunistic infections and pathological findings in Ghanaian AIDS patients and their sexual partners.
    Ayisi NK; Wiredu EK; Sata T; Nyadedzor C; Tsiagbe VK; Newman M; Cofie CN; Taneguchi K
    East Afr Med J; 1997 Dec; 74(12):784-91. PubMed ID: 9557423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic immune globulin in children with HIV disease.
    Mofenson LM; Nugent R
    N Engl J Med; 1995 Mar; 332(11):750-2. PubMed ID: 7854391
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of intravenous 7S immunoglobulins at high doses in HIV-related immunological pathology].
    Fiori GP
    Clin Ter; 1994 Apr; 144(4):301-5. PubMed ID: 8205754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Home health care costs: intravenous immunoglobulin home infusion therapy.
    Bielory L; Long GC
    Ann Allergy Asthma Immunol; 1995 Mar; 74(3):265-8. PubMed ID: 7889384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Mofenson LM; Moye J; Bethel J; Hirschhorn R; Jordan C; Nugent R
    JAMA; 1992 Jul 22-29; 268(4):483-8. PubMed ID: 1352363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis for opportunistic infections in an era of effective antiretroviral therapy.
    Powderly WG
    Clin Infect Dis; 2000 Aug; 31(2):597-601. PubMed ID: 10987727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of wasting and opportunistic infections in HIV-infected patients in West Africa: a realistic and necessary strategy before antiretroviral treatment].
    Ledru é ; Sanou PT; Dembele M; Dahourou H; Zoubga A; Durand G
    Sante; 1999; 9(5):293-300. PubMed ID: 10657773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.